Work

A Phase 2 Study of Fludarabine and Rituximab for the Treatment of Marginal Zone Lymphomas.

Year: 2007

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v110.11.1358.1358

Authors: Jennifer R. Brown, Jonathan Friedberg, Yang Feng, Kimberly Phillips, Jennifer C. Clark, Paola dal Cin, Robin Joyce, David C. Fisher, Richard I. Fisher, Ronald W. Takvorian, Jane Liesveld, Diana Marquis, Donna Neuberg, Arnold S. Freedman

Institutions: Dana-Farber Cancer Institute, University of Rochester Medicine, University of Rochester, Brigham and Women's Hospital, Beth Israel Deaconess Medical Center, Massachusetts General Hospital

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2551329224

FWCI: 0.416

Cites:

Cited by: 3

Related to: 10